Painting in the psychedelics field

This course will be a gateway for people who want to explore psychedelics for healing (and self-development). Through my experience with building Psychedelics Courses, I see there are many courses for becoming a therapist (which is also valuable), but not much about how to do psychedelics responsibly and to improve your own mental health.

At the same time, 90+% of trips are done by people at home (with the rest at retreats and <1% at clinical trials). I want to make relatively cheap resources (<$99) for this audience. Building on four years of diving into the research, my psychology degree, my girlfriend’s nine years as a licensed therapist (and coach), and a never-ending fascination with psychedelics, this will bring all of this together.

I’m still working out the details, but expect some announcements in the coming weeks.

I’m leaving this here as I’m spending about two hours per day (and with a virtual assistant spending about five hours per day too) updating the resources on Blossom. This means adding new research articles, full summaries (also of our older coverage), trials, events, etc.

We’re adding to the existing database and greatly expanding on what is currently available.

Currently (just before April), we’re conducting interviews to determine what we can best make to help people succeed in psychedelic research (as broadly defined as possible).

Some of the possible focus areas include: expanding the reports (which are a type of living review), help provide information about research centres and connect people, provide more frequent analyses of the latest research (in a members-only newsletter).

Update: Many articles now have full summaries and some of the reports have been updated too. I have moved house and attended PS2023, so alas fewer updates than hoped for.

Based on three years of experience studying the science of psychedelics, I want to launch a mini course that introduces people to the field. The course would cover the basics of the science and my/our perspective on where the field is going (e.g. what results to expect from ongoing trials).

The information for making this course will also overlap with my talk at Psychedelic Science 2023, where I will cover psychedelic research (history, current, and future). So I foresee a synergy between the two efforts.

Update: I’ve given the talk, but will make a slightly different course in the next quarter

We’re entirely remaking the courses website to include individual pages for courses and better search functionality.

Update: The new courses site is live (middle/end of January) and will be filled in throughout February.

Based on three years of experience studying the science of psychedelics, I want to launch a mini course that introduces people to the field. The course would cover the basics of the science and my/our perspective on where the field is going (e.g. what results to expect from ongoing trials).

The goal is to make the course low-priced (think 20-50 euros) so that many can use it as a good industry starting point or get an overview if you’re focussed on your specific area.

Update: This is been delayed to next quarter, and possibly will be a longer (more extensive) course.

The database (individual data points) is starting to be ‘complete’. We are now looking into getting the data in more overview pages.

For example, we are building an overview of all the ‘original’ studies, showing how many people have gone through the trials. Another project we’re working on is showcasing how many studies have been done for specific topics (e.g. depression) and writing a longer explainer on this topic.

Update: The next visualisation is live, see here.

Over the last few months, we’ve been highlighting more and more what companies are doing in the psychedelic space. Now we also want to expand the information collected in our database.

Just as we’ve done for papers & trials, we will provide more information on the companies working on psychedelics.

Next to the individual data points, we will also expand to cover more company data in overview pages.

Update: There were some updates on this front, but I spent more time on other projects.

Now that we have a basic version of nearly all topics covered by psychedelics, we want to dive deeper in partnership with some of the best psychedelic companies.

We have now (mid-May 2022) finished one paid report (to be published after review) and have a much more extensive report in the works together with a partner.

Next to that partnership, we remain open to partnering on other reports or paid engagements.

Over the last few months, we’ve been highlighting more and more what companies are doing in the psychedelic space. Now we also want to expand the information collected in our database.

Just as we’ve done for papers & trials, we will provide more information on the companies working on psychedelics.

Next to the individual data points, we will also expand to cover more company data in overview pages.

The reports bring to life the information from the databases, they are each an introduction to a specific topic (e.g. depression), compound (e.g. MDMA), or country (e.g. Switzerland).

Next to finishing our first versions of the reports, we are actively looking for collaborators to help make more detailed versions of the reports.

Since Q3 2021 we’ve been working on redesigning Blossom. This includes the new logo and styling, but also a new way of displaying the databases and individual pages (e.g. of a single paper).

The biggest changes here will be the search and individual pages for papers and companies that we’re working on behind the scenes.

Running since 2019, Blossom has been funded primarily by the personal funds of our founder. We are now actively working on recruiting partners to work with as well as emploring individual users of the database to chip in if the information we provide is valuable to them.

Contact us if you’re interested in cooperating.